Cargando…
Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a worldwide public health pandemic with a high mortality rate, among severe cases. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. It is important to ensure early detection of the virus to curb disease pr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179801/ https://www.ncbi.nlm.nih.gov/pubmed/34103920 http://dx.doi.org/10.2147/TCRM.S308961 |
_version_ | 1783703865447677952 |
---|---|
author | Tu, Changli Wang, Guojie Geng, Yayuan Guo, Na Cui, Ning Liu, Jing |
author_facet | Tu, Changli Wang, Guojie Geng, Yayuan Guo, Na Cui, Ning Liu, Jing |
author_sort | Tu, Changli |
collection | PubMed |
description | BACKGROUND: Coronavirus disease 2019 (COVID-19) is a worldwide public health pandemic with a high mortality rate, among severe cases. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. It is important to ensure early detection of the virus to curb disease progression to severe COVID-19. This study aims to establish a clinical-nomogram model to predict the progression to severe COVID-19 in a timely and efficient manner. METHODS: This retrospective study included 202 patients with COVID-19 who were admitted to the Fifth Affiliated Hospital of Sun Yat-sen University and Shiyan Taihe Hospital from January 17 to April 30, 2020. The patients were randomly assigned to the training dataset (n = 163, with 43 progressing to severe COVID-19) or the validation dataset (n = 39, with 10 progressing to severe COVID-19) at a ratio of 8:2. The optimal subset algorithm was applied to filter for the clinical factors most relevant to the disease progression. Based on these factors, the logistic regression model was fit to distinguish severe (including severe and critical cases) from non-severe (including mild and moderate cases) COVID-19. Sensitivity, specificity, and area under the curve (AUC) were calculated using the R software package to evaluate prediction performance. A clinical nomogram was established and performance assessed using the discrimination curve. RESULTS: Risk factors, including demographic data, symptoms, laboratory and image findings, were recorded for the 202 patients. Eight of the 53 variables that were entered into the selection process were selected via the best subset algorithm to establish the predictive model; they included gender, age, BMI, CRP, D-dimer, TP, ALB, and involved-lobe. AUC, sensitivity, and specificity were 0.91, 0.84 and 0.86 for the training dataset, and 0.87, 0.66, and 0.80 for the validation dataset. CONCLUSION: We established an efficient and reliable clinical nomogram model which showed that gender, age, and initial indexes including BMI, CRP, D-dimer, involved-lobe, TP, and ALB could predict the risk of progression to severe COVID-19. |
format | Online Article Text |
id | pubmed-8179801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-81798012021-06-07 Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease Tu, Changli Wang, Guojie Geng, Yayuan Guo, Na Cui, Ning Liu, Jing Ther Clin Risk Manag Original Research BACKGROUND: Coronavirus disease 2019 (COVID-19) is a worldwide public health pandemic with a high mortality rate, among severe cases. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. It is important to ensure early detection of the virus to curb disease progression to severe COVID-19. This study aims to establish a clinical-nomogram model to predict the progression to severe COVID-19 in a timely and efficient manner. METHODS: This retrospective study included 202 patients with COVID-19 who were admitted to the Fifth Affiliated Hospital of Sun Yat-sen University and Shiyan Taihe Hospital from January 17 to April 30, 2020. The patients were randomly assigned to the training dataset (n = 163, with 43 progressing to severe COVID-19) or the validation dataset (n = 39, with 10 progressing to severe COVID-19) at a ratio of 8:2. The optimal subset algorithm was applied to filter for the clinical factors most relevant to the disease progression. Based on these factors, the logistic regression model was fit to distinguish severe (including severe and critical cases) from non-severe (including mild and moderate cases) COVID-19. Sensitivity, specificity, and area under the curve (AUC) were calculated using the R software package to evaluate prediction performance. A clinical nomogram was established and performance assessed using the discrimination curve. RESULTS: Risk factors, including demographic data, symptoms, laboratory and image findings, were recorded for the 202 patients. Eight of the 53 variables that were entered into the selection process were selected via the best subset algorithm to establish the predictive model; they included gender, age, BMI, CRP, D-dimer, TP, ALB, and involved-lobe. AUC, sensitivity, and specificity were 0.91, 0.84 and 0.86 for the training dataset, and 0.87, 0.66, and 0.80 for the validation dataset. CONCLUSION: We established an efficient and reliable clinical nomogram model which showed that gender, age, and initial indexes including BMI, CRP, D-dimer, involved-lobe, TP, and ALB could predict the risk of progression to severe COVID-19. Dove 2021-06-01 /pmc/articles/PMC8179801/ /pubmed/34103920 http://dx.doi.org/10.2147/TCRM.S308961 Text en © 2021 Tu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Tu, Changli Wang, Guojie Geng, Yayuan Guo, Na Cui, Ning Liu, Jing Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease |
title | Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease |
title_full | Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease |
title_fullStr | Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease |
title_full_unstemmed | Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease |
title_short | Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease |
title_sort | establishment of a clinical nomogram model to predict the progression of covid-19 to severe disease |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179801/ https://www.ncbi.nlm.nih.gov/pubmed/34103920 http://dx.doi.org/10.2147/TCRM.S308961 |
work_keys_str_mv | AT tuchangli establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease AT wangguojie establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease AT gengyayuan establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease AT guona establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease AT cuining establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease AT liujing establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease |